AI Valuations Could Face a Reset if Leading Labs Miss Expectations

A disappointing public-market performance by Anthropic or OpenAI could sharply undermine the current AI funding boom, particularly if either company misses expectations for revenue traction or margins. The analysis says such a miss could reset AI valuations and deprive many companies of access to capital, though it does not claim that either lab will underperform.

Current funding levels are tied to the possibility of building trillion-dollar companies within the lifecycle of a venture fund. AI may have increased startup upside by one or two orders of magnitude compared with the historical venture outcome of roughly $10 billion to $50 billion, or $100 billion at the high end; however, if investors stop expecting more trillion-dollar companies, existing valuations and investment volumes may become difficult to justify.

The analysis also questions Series B and Series C rounds for companies with lower scale, slower growth, weaker talent density, and higher revenue multiples than leading labs. It argues that low scale is not disqualifying when a company has the right team for the challenge, but that a credible path to a trillion-dollar business requires world-class talent and the ability to assemble a very high density of it.